Incannex Healthcare Inc. (NASDAQ: IXHL)
$2.0250
+0.0550 ( +3.32% ) 6.2K
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.
Market Data
Open
$2.0250
Previous close
$1.9700
Volume
6.2K
Market cap
$35.64M
Day range
$1.9960 - $2.0650
52 week range
$0.9501 - $12.6800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 100 | Sep 30, 2024 |
8-k | 8K-related | 15 | Sep 30, 2024 |
8-k | 8K-related | 15 | Sep 10, 2024 |
8-k | 8K-related | 15 | Sep 10, 2024 |
8-k | 8K-related | 15 | Aug 05, 2024 |
5 | Other | 1 | Aug 02, 2024 |
8-k | 8K-related | 15 | Jul 30, 2024 |
8-k | 8K-related | 15 | May 30, 2024 |
10-q | Quarterly Reports | 78 | May 15, 2024 |
8-k | 8K-related | 15 | May 07, 2024 |